Literature DB >> 21189260

TBK1-associated protein in endolysosomes (TAPE) is an innate immune regulator modulating the TLR3 and TLR4 signaling pathways.

Chun-Hung Chang1, Li-Chun Lai, Hung-Chi Cheng, Kuan-Ru Chen, Ying-Zhang Syue, Hsueh-Chi Lu, Wan-Ying Lin, Shun-Hua Chen, Huei-Sheng Huang, Ai-Li Shiau, Huan-Yao Lei, Jun Qin, Pin Ling.   

Abstract

The innate immune system elicits the first wave of immune responses against pathogen infection. Its operational modes are complex and have yet to be defined. Here, we report the identification of an innate immune regulator termed TAPE (TBK1-associated protein in endolysosomes), previously known as CC2D1A/Freud-1/Aki-1, which modulates the TLR3 and TLR4 pathways. We found that TAPE activated the TBK1, NF-κB, and ERK pathways leading to IFN-β and inflammatory cytokine induction. TAPE was shown to colocalize with endosomal marker Rab5 and lysosomal marker LAMP1 in mammalian cells, suggesting that TAPE resided in endolysosomes. Knockdown of TAPE selectively impaired the TLR3 and endocytic TLR4 pathways to IFN-β induction. Furthermore, TAPE interacted and synergized with Trif to activate IFN-β. TAPE knockdown failed to block Trif-mediated IFN-β induction, whereas Trif knockdown impaired the TLR3 and TAPE cooperation on IFN-β induction, suggesting that TAPE acts upstream of Trif. Together, our data demonstrate a central role for TAPE in linking TLR3 and TLR4 to innate immune defenses at an early step.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21189260      PMCID: PMC3044961          DOI: 10.1074/jbc.M110.164632

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  Triggering the interferon antiviral response through an IKK-related pathway.

Authors:  Sonia Sharma; Benjamin R tenOever; Nathalie Grandvaux; Guo-Ping Zhou; Rongtuan Lin; John Hiscott
Journal:  Science       Date:  2003-04-17       Impact factor: 47.728

2.  The cytosolic nucleic acid sensor LRRFIP1 mediates the production of type I interferon via a beta-catenin-dependent pathway.

Authors:  Pengyuan Yang; Huazhang An; Xingguang Liu; Mingyue Wen; Yuanyuan Zheng; Yaocheng Rui; Xuetao Cao
Journal:  Nat Immunol       Date:  2010-05-09       Impact factor: 25.606

3.  Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways.

Authors:  Akio Matsuda; Yutaka Suzuki; Goichi Honda; Shuji Muramatsu; Osamu Matsuzaki; Yukiko Nagano; Takahiro Doi; Kunitada Shimotohno; Takeshi Harada; Eisuke Nishida; Hiroshi Hayashi; Sumio Sugano
Journal:  Oncogene       Date:  2003-05-22       Impact factor: 9.867

Review 4.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

Review 5.  Pattern recognition receptors and inflammation.

Authors:  Osamu Takeuchi; Shizuo Akira
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

Review 6.  Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application.

Authors:  Aimee L Jackson; Peter S Linsley
Journal:  Nat Rev Drug Discov       Date:  2010-01       Impact factor: 84.694

7.  Freud-1: A neuronal calcium-regulated repressor of the 5-HT1A receptor gene.

Authors:  Xiao-Ming Ou; Sylvie Lemonde; Hamed Jafar-Nejad; Christopher D Bown; Aya Goto; Anastasia Rogaeva; Paul R Albert
Journal:  J Neurosci       Date:  2003-08-13       Impact factor: 6.167

8.  Synergistic anti-HSV effect of tumor necrosis factor alpha and interferon gamma in human corneal fibroblasts is associated with interferon beta induction.

Authors:  S H Chen; J E Oakes; R N Lausch
Journal:  Antiviral Res       Date:  1993-09       Impact factor: 5.970

9.  IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway.

Authors:  Katherine A Fitzgerald; Sarah M McWhirter; Kerrie L Faia; Daniel C Rowe; Eicke Latz; Douglas T Golenbock; Anthony J Coyle; Sha-Mei Liao; Tom Maniatis
Journal:  Nat Immunol       Date:  2003-05       Impact factor: 25.606

10.  CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer.

Authors:  Cameron R Stewart; Lynda M Stuart; Kim Wilkinson; Janine M van Gils; Jiusheng Deng; Annett Halle; Katey J Rayner; Laurent Boyer; Ruiqin Zhong; William A Frazier; Adam Lacy-Hulbert; Joseph El Khoury; Douglas T Golenbock; Kathryn J Moore
Journal:  Nat Immunol       Date:  2009-12-27       Impact factor: 25.606

View more
  19 in total

1.  CC2D1A is a regulator of ESCRT-III CHMP4B.

Authors:  Nicolas Martinelli; Bettina Hartlieb; Yoshiko Usami; Charles Sabin; Aurelien Dordor; Nolwenn Miguet; Sergiy V Avilov; Euripedes A Ribeiro; Heinrich Göttlinger; Winfried Weissenhorn
Journal:  J Mol Biol       Date:  2012-03-08       Impact factor: 5.469

Review 2.  TLR3 immunity to infection in mice and humans.

Authors:  Shen-Ying Zhang; Melina Herman; Michael J Ciancanelli; Rebeca Pérez de Diego; Vanessa Sancho-Shimizu; Laurent Abel; Jean-Laurent Casanova
Journal:  Curr Opin Immunol       Date:  2013-01-03       Impact factor: 7.486

3.  Conditional Deletion of CC2D1A Reduces Hippocampal Synaptic Plasticity and Impairs Cognitive Function through Rac1 Hyperactivation.

Authors:  Cheng-Yi Yang; Ting-Hsuan Yu; Wan-Ling Wen; Pin Ling; Kuei-Sen Hsu
Journal:  J Neurosci       Date:  2019-04-16       Impact factor: 6.167

4.  Regulation of CHMP4/ESCRT-III function in human immunodeficiency virus type 1 budding by CC2D1A.

Authors:  Yoshiko Usami; Sergei Popov; Eric R Weiss; Christie Vriesema-Magnuson; Arianna Calistri; Heinrich G Göttlinger
Journal:  J Virol       Date:  2012-01-18       Impact factor: 5.103

5.  Toll-Like Receptor 4 Promotes Th17 Lymphocyte Infiltration Via CCL25/CCR9 in Pathogenesis of Experimental Autoimmune Encephalomyelitis.

Authors:  Ying Zhang; Jingjing Han; Meili Wu; Lu Xu; Yu Wang; Wen Yuan; Fang Hua; Hongbin Fan; Fuxing Dong; Xuebin Qu; Ruiqin Yao
Journal:  J Neuroimmune Pharmacol       Date:  2019-05-08       Impact factor: 4.147

6.  The Molecular Chaperone GRP78 Contributes to Toll-like Receptor 3-mediated Innate Immune Response to Hepatitis C Virus in Hepatocytes.

Authors:  Dahai Wei; Nan L Li; Yanli Zeng; Baoming Liu; Kattareeya Kumthip; Tony T Wang; Dezheng Huo; Jesse F Ingels; Lu Lu; Jia Shang; Kui Li
Journal:  J Biol Chem       Date:  2016-04-20       Impact factor: 5.157

7.  TBK1-associated protein in endolysosomes (TAPE)/CC2D1A is a key regulator linking RIG-I-like receptors to antiviral immunity.

Authors:  Kuan-Ru Chen; Chun-Hung Chang; Ching-Yu Huang; Chun-Yang Lin; Wan-Ying Lin; Yin-Chiu Lo; Chia-Yu Yang; En-Wei Hsing; Lin-Fang Chen; Shin-Ru Shih; Ai-Li Shiau; Huan-Yao Lei; Tse-Hua Tan; Pin Ling
Journal:  J Biol Chem       Date:  2012-07-25       Impact factor: 5.157

8.  Cc2d1a Loss of Function Disrupts Functional and Morphological Development in Forebrain Neurons Leading to Cognitive and Social Deficits.

Authors:  Adam W Oaks; Marta Zamarbide; Dimira E Tambunan; Emanuela Santini; Stefania Di Costanzo; Heather L Pond; Mark W Johnson; Jeff Lin; Dilenny M Gonzalez; Jessica F Boehler; Guangying K Wu; Eric Klann; Christopher A Walsh; M Chiara Manzini
Journal:  Cereb Cortex       Date:  2017-02-01       Impact factor: 5.357

9.  CC2D1A regulates human intellectual and social function as well as NF-κB signaling homeostasis.

Authors:  M Chiara Manzini; Lan Xiong; Ranad Shaheen; Dimira E Tambunan; Stefania Di Costanzo; Vanessa Mitisalis; David J Tischfield; Antonella Cinquino; Mohammed Ghaziuddin; Mehtab Christian; Qin Jiang; Sandra Laurent; Zohair A Nanjiani; Saima Rasheed; R Sean Hill; Sofia B Lizarraga; Danielle Gleason; Diya Sabbagh; Mustafa A Salih; Fowzan S Alkuraya; Christopher A Walsh
Journal:  Cell Rep       Date:  2014-07-24       Impact factor: 9.423

10.  TLR2 and TLR4 mediate differential responses to limb ischemia through MyD88-dependent and independent pathways.

Authors:  Ulka Sachdev; Xiangdong Cui; Ryan McEnaney; Tian Wang; Kelly Benabou; Edith Tzeng
Journal:  PLoS One       Date:  2012-11-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.